Rhythm Pharmaceuticals Inc [NASDAQ: RYTM] stock went on an upward path that rose over 36.63% on Wednesday, amounting to a one-week price increase of more than 36.00%.
Over the last 12 months, RYTM stock rose by 58.99%. The one-year Rhythm Pharmaceuticals Inc stock forecast points to a potential upside of 11.07. The average equity rating for RYTM stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $5.66 billion, with 63.49 million shares outstanding and 58.19 million shares in the current float. Compared to the average trading volume of 667.39K shares, RYTM stock reached a trading volume of 4786638 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Rhythm Pharmaceuticals Inc [RYTM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RYTM shares is $100.08 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RYTM stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for Rhythm Pharmaceuticals Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on July 07, 2025. The new note on the price target was released on April 07, 2025, representing the official price target for Rhythm Pharmaceuticals Inc stock. Previously, the target price had yet another raise to $78, while Stifel analysts kept a Buy rating on RYTM stock.
The Price to Book ratio for the last quarter was 298.26, with the Price to Cash per share for the same quarter was set at 4.94.
RYTM Stock Performance Analysis:
Rhythm Pharmaceuticals Inc [RYTM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 36.00. With this latest performance, RYTM shares gained by 30.67% in over the last four-week period, additionally plugging by 49.28% over the last 6 months – not to mention a rise of 58.99% in the past year of trading.
Insight into Rhythm Pharmaceuticals Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Rhythm Pharmaceuticals Inc [RYTM] shares currently have an operating margin of -126.13% and a Gross Margin at 89.12%. Rhythm Pharmaceuticals Inc’s Net Margin is presently recorded at -127.12%.
Return on Equity for this stock declined to -52.28%, with Return on Assets sitting at -52.28%.
Rhythm Pharmaceuticals Inc [RYTM] Institutonal Ownership Details
There are presently around $107.02%, or 107.74% of RYTM stock, in the hands of institutional investors. The top three institutional holders of RYTM stocks are: PRIMECAP MANAGEMENT CO/CA/ with ownership of 7.31 million shares, which is approximately 11.9852%. BLACKROCK INC., holding 6.74 million shares of the stock with an approximate value of $$276.82 million in RYTM stocks shares; and BLACKROCK INC., currently with $$262.72 million in RYTM stock with ownership which is approximately 10.4871%.
